Eon Ting

Join this conversation to gain insights on working together on access pathways that support sustainable access for patients.

With more diverse approaches to manage drug budgets while still ensuring critical medicines are accessible to patients, this discussion will explore practical ways to work together on streamlining negotiations, considering a broader lifecycle mindset, and ultimately, creating shared value for all parties.

You’ll return with strategies to:

• Navigate pricing frameworks: demystify different approaches and criteria across the Canadian landscape
• Consider lifecycle planning: align evidence, value propositions, and timing from launch through maturity to support payer discussions
• Find common ground: discuss where policies align, tailor where they diverge, and build collaborative tactics that balance cost containment with equitable, timely patient access

Valuable insights can be drawn from international examples of navigating market access. Understand different international pricing models, regulatory landscapes, and reimbursement strategies, along with recommendations. Master the success factors to:

• Compare key approaches to market access with a view to identifying best practices applicable to the Canadian landscape.
• Explore international market access pathways and supporting projects.
• Learn how global regulatory trends and policy shifts impact Canadian market access and which proactive strategies can be implemented for long-term success.

Perfect a future-proof approach to market access with insights from beyond Canada’s borders.